Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population
Global burden of breast cancer is expected to increase to >2 million new cases every year by 2030 and 10% of these are likely to have hereditary breast and ovarian cancer syndrome. Identifying these individuals by pedigree and BRCA1/2 mutation analyses will enable us to offer targeted mutation te...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-02-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317694303 |